FDA decision on Novocure’s TTFields for NSCLC brain metastases expected in Q4 2026
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
Beijing Urban Construction Design Public Float Falls Below 25% Minimum
The company’s public float was 23.70% as of Oct. 30, below the required 25% minimum.
L impact | REGULATION | Oct 30, 2026, 04:03 AM UTC
USFDA Approves Sun Pharma’s Supplemental Biologics License Application for Ilumya
M impact | REGULATION | Oct 30, 2026, 02:37 AM UTC
Indonesia Exempts Coal for Off-Grid Plants From Domestic Market Obligation
M impact | REGULATION | Oct 30, 2026, 02:13 AM UTC
Prosecutors Appeal Oh Se-hoon’s Second-Trial Acquittal
A special counsel appealed Oh Se-hoon’s acquittal in a second trial on political-fund law charges.
L impact | REGULATION | Oct 30, 2026, 01:51 AM UTC
France to Deploy Officers for Halloween Protests
The French government announced the deployment amid the risk of violence during Halloween protests.
M impact | REGULATION | Oct 30, 2026, 01:34 AM UTC
Netanyahu Wins Israeli Election, but His Bloc Falls Short of a Majority
The final count shows Netanyahu won the election, but his bloc did not secure a majority.
M impact | REGULATION | Oct 30, 2026, 01:34 AM UTC